189 results on '"Zwijnenburg, Danny A."'
Search Results
2. Transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohort
3. Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases
4. Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma
5. Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
6. Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140
7. Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer.
8. Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases
9. The molecular landscape of ETMR at diagnosis and relapse
10. Iron‐responsive element of Divalent metal transporter 1 (Dmt1) controls Notch‐mediated cell fates.
11. Abstract 3571: The ITCC-P4 sustainable platform of fully characterized PDXs supports the preclinical proof-of-concept drug testing of high-risk pediatric tumor models
12. Abstract 234: ITCC-P4: Genomic profiling and analyses of pediatric patient tumor and patient-derived xenograft (PDX) models for high throughput in vivo testing
13. Supplementary Figure Legends 1-6, Methods from Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines
14. Supplementary Figure 5 from Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines
15. Supplementary Figure 4 from Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines
16. Supplementary Figure 1 from Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines
17. Supplementary Figure 6 from Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines
18. Supplementary Figure 2 from Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines
19. Supplementary Figure 3 from Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines
20. Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
21. Data from RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma
22. Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
23. Supplementary Figures from RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma
24. Supplementary Figure 6 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
25. Supplementary Figure 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
26. Supplementary Figure 4 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
27. Supplementary Table 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
28. Supplementary Figure 3 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
29. Supplementary Figure 5 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
30. Supplementary Table 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
31. Supplementary Figure 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
32. Supplementary Figure Legends 1-6, Tables 1-2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
33. Iron-responsive element of Divalent metal transporter 1 (Dmt1) controls Notch-mediated cell fates
34. Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
35. Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
36. Abstract 2616: Stemness factors nanog and oct4 contribute to epithelial-to-mesenchymal transition and are predictive for outcome in esophageal adenocarcinoma
37. INSP-15. ITCC-P4: A sustainable platform of molecularly well-characterized PDX models of pediatric cancers for high throughputin vivo testing
38. Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
39. Additional file 16 of Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140
40. Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
41. Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
42. The landscape of genomic alterations across childhood cancers
43. Author Correction: The landscape of genomic alterations across childhood cancers
44. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels
45. Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma
46. Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma
47. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
48. An immature subset of neuroblastoma cells synthesizes retinoic acid and depends on this metabolite
49. The landscape of genomic alterations across childhood cancers
50. Specific and Sensitive Detection of Neuroblastoma mRNA Markers by Multiplex RT-qPCR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.